Gilead Sciences
GILD
#96
Rank
A$252.09 B
Marketcap
A$203.10
Share price
0.91%
Change (1 day)
14.82%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2025 (TTM): A$14.94 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are A$29.44 Billion. , an increase over its 2024 earnings that were of A$0.99 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2025

Annual earnings

Year Earnings Change
2025 A$14.14 B1319.86%
2024 A$0.99 B-89.94%
2023 A$9.90 B17.97%
2022 A$8.39 B-29.77%
2021 A$11.95 B395.99%
2020 A$2.41 B-67.66%
2019 A$7.45 B-33.84%
2018 A$11.26 B-42.35%
2017 A$19.53 B-20.87%
2016 A$24.68 B-21.06%
2015 A$31.27 B45.8%
2014 A$21.45 B253.01%
2013 A$6.07 B16.51%
2012 A$5.21 B-1.07%
2011 A$5.27 B-6.71%
2010 A$5.65 B11.75%
2009 A$5.05 B29.5%
2008 A$3.90 B19.11%
2007 A$3.27 B-455.74%
2006 -A$0.93 Billion-154.93%
2005 A$1.67 B76.99%
2004 A$0.94 B-266.16%
2003 -A$0.58 Billion-638.24%
2002 A$0.10 B31.5%
2001 A$80.6 M-242.15%
2000 -A$56.71 Million-40.2%
1999 -A$94.83 Million31.85%
1998 -A$71.92 Million8.73%
1997 -A$66.14 Million27.22%
1996 -A$51.99 Million
1994 -A$49.54 Million26.57%
1993 -A$39.14 Million46.49%
1992 -A$26.72 Million362.5%
1991 -A$5.78 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$48.45 B 242.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$14.71 B 4.03%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$9.52 B-32.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$37.15 B 162.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.96 B-8.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.24 B-84.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$1.71 B-87.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$6.72 B-52.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$32.38 B 128.88%๐Ÿ‡บ๐Ÿ‡ธ USA